title: Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts.
abstract: Mucolipidosis II (ML-II) is a fatal inherited metabolic disease caused by deficiency of GlcNAc-phosphotransferase, which plays a role in generating the mannose 6-phosphate recognition marker on lysosomal enzymes. In ML-II, many lysosomal acid hydrolases are mistargeted out of cells, and lysosomes become filled with undigested substrates, which explains inclusion cell disease as an alternative name for this disease. In this study, we revealed various cellular phenotypes in ML-II skin fibroblasts. We quantitated phospholipid and cholesterol within cells and showed ~2-fold accumulation in ML-II as compared with normal cells. Lysosomal pH of ML-II cells was higher than that of normal cells (5.29 ± 0.08 versus 4.79 ± 0.10, p < 0.001). The proliferated lysosomes in ML-II cells were accumulated ~3-fold in amount as compared with normal cells. Intracellular logistics including endocytosis and mannose 6-phosphate receptor recycling were impaired in ML-II cells. To confirm whether these ML-II cellular phenotypes derive from deficient lysosomal acid hydrolases within lysosomes, we performed supplementation of lysosomal enzymes using a partially purified total enzyme mixture, which was derived from the conditioned culture medium of normal skin fibroblasts after NH(4)Cl treatment. This supplementation corrected all of the previously described ML-II phenotypes. In addition, the autophagic and mitochondrial impairment that we have previously reported improved, and inclusion bodies disappeared on electron micrography following total lysosomal enzyme supplementation. Our results indicate that various cellular phenotypes in ML-II are caused by the deficiency of many lysosomal enzymes and massive accumulation of undigested substrates.
authors.affiliation: Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan. otomo@ped.med.osaka-u.ac.jp
authors.forename: Takanobu
authors.initials: T
authors.lastname: Otomo
authors.forename: Katsumi
authors.initials: K
authors.lastname: Higaki
authors.forename: Eiji
authors.initials: E
authors.lastname: Nanba
authors.forename: Keiichi
authors.initials: K
authors.lastname: Ozono
authors.forename: Norio
authors.initials: N
authors.lastname: Sakai
mesh_terms: D001343:Autophagy; D002460:Cell Line; D003470:Culture Media / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016464:Lysosomal Storage Diseases / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism*; D008661:Metabolism, Inborn Errors / Q000378:metabolism; D008856:Microscopy, Fluorescence / Q000379:methods; D008954:Models, Biological; D009081:Mucolipidoses / Q000378:metabolism*; D010641:Phenotype; D012867:Skin / Q000378:metabolism*; D013110:Sphingosine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D003470:Culture Media; C527864:N-(5-(5,7-dimethyl Bodipy)-1-pentanoyl)-erythrosphingosine; D013110:Sphingosine